BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
156 results:

  • 1. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
    Shuaib M; Chaudhri S; Kumar S
    Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association between NDRG1 protein expression and aggressive features of breast cancer: a systematic review and meta-analysis.
    Kotepui K; Kotepui M; Majima HJ; Tangpong J
    BMC Cancer; 2023 Oct; 23(1):1003. PubMed ID: 37858101
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.
    Fares J; Petrosyan E; Kanojia D; Dmello C; Cordero A; Duffy JT; Yeeravalli R; Sahani MH; Zhang P; Rashidi A; Arrieta VA; Ulasov I; Ahmed AU; Miska J; Balyasnikova IV; James CD; Sonabend AM; Heimberger AB; Lesniak MS
    J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 37847564
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Meta-analysis of the application value of indocyanine green fluorescence imaging in guiding sentinel lymph node biopsy for breast cancer.
    Wang P; Shuai J; Leng Z; Ji Y
    Photodiagnosis Photodyn Ther; 2023 Sep; 43():103742. PubMed ID: 37567333
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
    Bauer TM; Moore KN; Rader JS; Simpkins F; Mita AC; Beck JT; Hart L; Chu Q; Oza A; Tinker AV; Imedio ER; Kumar S; Mugundu G; Jenkins S; Chmielecki J; Jones S; Spigel D; Fu S
    Target Oncol; 2023 Jul; 18(4):517-530. PubMed ID: 37278879
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner.
    Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson LG
    Cancer Res Commun; 2022 Mar; 2(3):182-201. PubMed ID: 36874405
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of the NDRG1 in the pathogenesis and treatment of breast cancer.
    Zhao X; Richardson DR
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188871. PubMed ID: 36841367
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluating the effect of nurses' supportive and educational care on GATA2 gene expression and quality of life in patients with endometriosis.
    Zheng HY
    Cell Mol Biol (Noisy-le-grand); 2022 Aug; 68(8):145-150. PubMed ID: 36800818
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Overview of the miR-29 family members' function in breast cancer.
    Amirian M; Jafari-Nozad AM; Darroudi M; Farkhondeh T; Samarghandian S
    Int J Biol Macromol; 2023 Mar; 230():123280. PubMed ID: 36652981
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative breast cancer Progression.
    López-Tejada A; Griñán-Lisón C; González-González A; Cara FE; Luque RJ; Rosa-Garrido C; Blaya-Cánovas JL; Navarro-Ocón A; Valenzuela-Torres M; Parra-López M; Calahorra J; Blancas I; Marchal JA; Granados-Principal S
    Int J Biol Sci; 2023; 19(1):204-224. PubMed ID: 36594086
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. SMAD9-mycn positive feedback loop represents a unique dependency for mycn-amplified neuroblastoma.
    Tan K; Mo J; Li M; Dong Y; Han Y; Sun X; Ma Y; Zhu K; Wu W; Lu L; Liu J; Zhao K; Zhang L; Tang Y; Lv Z
    J Exp Clin Cancer Res; 2022 Dec; 41(1):352. PubMed ID: 36539767
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.
    Ho GY; Kyran EL; Bedo J; Wakefield MJ; Ennis DP; Mirza HB; Vandenberg CJ; Lieschke E; Farrell A; Hadla A; Lim R; Dall G; Vince JE; Chua NK; Kondrashova O; Upstill-Goddard R; Bailey UM; Dowson S; Roxburgh P; Glasspool RM; Bryson G; Biankin AV; ; Cooke SL; Ratnayake G; McNally O; Traficante N; ; DeFazio A; Weroha SJ; Bowtell DD; McNeish IA; Papenfuss AT; Scott CL; Barker HE
    Cancer Res; 2022 Dec; 82(23):4457-4473. PubMed ID: 36206301
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor.
    Ahmed EA; Rajendran P; Scherthan H
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682549
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. An improved CUT&RUN method for regulation network reconstruction of low abundance transcription factor.
    Bai H; Lin M; Meng Y; Bai H; Cai S
    Cell Signal; 2022 Aug; 96():110361. PubMed ID: 35643226
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors
    Khazan N; Kim KK; Hansen JN; Singh NA; Moore T; Snyder CWA; Pandita R; Strawderman M; Fujihara M; Takamura Y; Jian Y; Battaglia N; Yano N; Teramoto Y; Arnold LA; Hopson R; Kishor K; Nayak S; Ojha D; Sharon A; Ashton JM; Wang J; Milano MT; Miyamoto H; Linehan DC; Gerber SA; Kawar N; Singh AP; Tabdanov ED; Dokholyan NV; Kakuta H; Jurutka PW; Schor NF; Rowswell-Turner RB; Singh RK; Moore RG
    J Med Chem; 2022 Apr; 65(8):6039-6055. PubMed ID: 35404047
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Investigation of Chemopreventive and Antiproliferative Potential of
    Ahmad B; Khan MR; Shah NA; Kondratyuk TP; Ahmed N; Pezzuto JM; Gul A; Khattak A
    Integr Cancer Ther; 2022; 21():15347354211069934. PubMed ID: 34991410
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.
    Zhai Z; Mu T; Zhao L; Li Y; Zhu D; Pan Y
    Bioengineered; 2022 Jan; 13(1):83-95. PubMed ID: 34951340
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. NDRG1 in Aggressive breast cancer Progression and Brain Metastasis.
    Villodre ES; Hu X; Eckhardt BL; Larson R; Huo L; Yoon EC; Gong Y; Song J; Liu S; Ueno NT; Krishnamurthy S; Pusch S; Tripathy D; Woodward WA; Debeb BG
    J Natl Cancer Inst; 2022 Apr; 114(4):579-591. PubMed ID: 34893874
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Regulation of tumor-associated macrophage (TAM) differentiation by NDRG2 expression in breast cancer cells.
    Lee S; Lee A; Lim J; Lim JS
    BMB Rep; 2022 Feb; 55(2):81-86. PubMed ID: 34743782
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Litigation in breast surgery: unique insights from the English National Health Service experience.
    O'Connell RL; Patani N; Machin JT; Briggs TWR; Irvine T; MacNeill FA
    BJS Open; 2021 May; 5(3):. PubMed ID: 33972991
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.